Europe Flowable Hemostats Market Forecast to 2028

Europe Flowable Hemostats Market Forecast to 2028

Europe Flowable Hemostats Market Forecast to 2028 – Regional Analysis – by Material (Porcine Gelatin and Bovine Gelatin), Product (Active Hemostats, Passive Hemostats, and Combination Hemostats), Application (General Surgery, Cardiac Surgery, Vascular Surgery, Orthopedic Surgery, Neuro & Spine Surgery, and Others), and End User (Hospital & Clinics, Ambulatory Surgery Centers, and Others)

Send Enquiry
Item ID: BMIRE00029827 Category: Tag:

$2,840 – $4,440

Description

The Europe flowable hemostats market is expected to grow from US$ 215.54 million in 2022 to US$ 328.23 million by 2028. It is estimated to grow at a CAGR of 7.3% from 2022 to 2028.

Increasing Number of Hospitals and Surgical Centers Fuel Europe Flowable Hemostats Market

The number of hospitals and surgical centers is increasing rapidly in developed and emerging regions. Such growth accelerates demand for surgical equipment (including medical devices and hemostat products) for lately established surgical centers and hospitals. In October 2020, the Prime Minister of the UK announced plans to invest around US$ 4.3 billion for the setting of 40 hospitals and a scheme for future funding for 48 hospitals by 2030. Furthermore, the growth in the healthcare sector offers lucrative opportunities for the flowable hemostats market. The healthcare industry has been encountering a rapid transformation in recent years. Various countries across the globe have favored advanced technologies in healthcare. With the need for better healthcare facilities, Technology-Enabled Care (TEC) solutions are being referred to in the healthcare systems, especially in emerging economies. Some of the primary factors, such as rising incidences of chronic illnesses, an increase in the aging population, and pediatric care, are helping boost the growth of the healthcare industry. With rising technical procedures, the effectiveness of topical hemostats may help improve clinical outcomes. Thus, the ideal topical hemostats would offer authentic and prompt bleeding control. Such significant growth in the number of hospitals and surgical centers demands high adoption of flowable hemostat products, ultimately offering lucrative growth opportunities for the market’s growth during the coming years.

Europe Flowable Hemostats Market Overview

The Europe market for flowable hemostats is spread across Germany, the UK, France, Italy, Spain, and the Rest of Europe. This regional market is expected to witness a steady growth rate of 7.3% from 2022 to 2028 due to the rise in the number of surgical procedures, increasing government initiatives, growing healthcare expenditure, and several other factors. Germany has some specific medical facilities and trained physicians to treat patients worldwide. Besides, the country has the most advanced medical training facilities, and doctors are required to undergo extensive education, residency, and practice. As per the study obtained from the German Federal Statistical Office, the country had nearly 951,936 hospital staff and approximately 1,903 hospitals in 2020, which is expected to increase the number of surgeries in the country over the coming years. The growing number of surgical procedures is a crucial factor behind the rise in the hemostats market in Germany. For instance, according to the German Society for Thoracic and Cardiovascular Surgery (GSTCVS), around 161,817 procedures were registered in 2019 across the country, out of which 92,809 were cardiac surgeries. Furthermore, Germany is the largest medical technology market and ranks third internationally. Approximately 11,000 medical devices are manufactured in the country, and two-thirds of its sales of medical devices were produced outside its domestic market. Germany is home to more than 30 dedicated cluster networks dedicated to innovative medical technology. The German Government’s national high-tech strategy 2020 developed as a broad, interdepartmental advance strategy. Thus, factors, such as the growing number of hospitals and the rise in the number of surgeries, are likely to boost this market during the forecast period.

Europe Flowable Hemostats Market Revenue and Forecast to 2028 (US$ Million)

Europe Flowable Hemostats Market Segmentation

The Europe flowable hemostats market is segmented into material, product, application, end user, and country.

Based on material, the Europe flowable hemostats market is bifurcated into bovine gelatin & porcine gelatin. The bovine gelatin segment held a larger share of the Europe flowable hemostats market in 2022.

In terms of product, the Europe flowable hemostats market is segmented into combination hemostats, passive hemostats, and active hemostats. The combination hemostats segment held the largest share of the Europe flowable hemostats market in 2022.

Based on application, the Europe flowable hemostats market is categorized into general surgery, cardiac surgery, vascular surgery, orthopedic surgery, neuro and spine surgery, and others. The general surgery segment held the largest share of the Europe flowable hemostats market in 2022.

Based on end user, the Europe flowable hemostats market is segmented into hospitals and clinics, ambulatory surgery centers, and others. The hospitals and clinics segment held the largest share of the Europe flowable hemostats market in 2022.

By country, the Europe flowable hemostats market is categorized into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Germany dominated the Europe flowable hemostats market in 2022.

Baxter International Inc, Ethicon (Johnson & Johnson), Pfizer Inc, Teleflex Incorporated, 3-D Matrix Medical Technology, Biom’up, and Aegis Lifesciences are some of the leading companies operating in the Europe flowable hemostats market.

Summary Info

Industry:

Pricing options:

, ,

Geographical coverage:

Year of Publication:

At 7.3% CAGR, the Europe Flowable Hemostats Market is Speculated to be Worth US$ 328.23 Million by 2028, Says the Research Team

According to the Research Team’ research, the Europe flowable hemostats market was valued at US$ 215.54 million in 2022 and is expected to reach US$ 328.23 million by 2028, registering a CAGR of 7.3% from 2022 to 2028. Increasing number of injuries and surgical procedures and rising geriatric population are among the critical factors attributed to the Europe flowable hemostats market expansion.

Population aging is a global phenomenon, effectively every country in the world is experiencing growth in the size and proportion of older persons in their population. The rising geriatric population directly affects the demand for hemostats, primarily due to higher susceptibility to various diseases among the population leading to a higher number of surgeries. According to the World Health Organization (WHO), the number and portion of people aged 60 years and older in the population is increasing. In 2019, the number of people aged 60 years and older was 1 billion. This number will increase to 1.4 billion by 2030 and 2.1 billion by 2050. This increase is occurring at an unprecedented pace and will accelerate in the coming decades, particularly in developing countries. According to a study conducted by “Queen Mary University of London’s William Harvey Research Institute,” the number of people aged 75 years or older undergoing surgery surged from 544,998 in 1999 to 1,012,517 in 2015. The average age of patients undergoing surgery surged from 47.5 years in 1999 to 54.2 years in 2015. By contrast, the average age of the English population increased from 38.3 to 39.7 years. The research further states, that if current trends continue, by 2030 more than 1.48 million people aged 75 years or older will have a surgical procedure annually. This represents 1 in 10 people in England and 1 in 5 people among those aged 75 years or older. Thus, an increase in the geriatric population is anticipated to propel the Europe flowable hemostats market during the forecast period.

On the contrary, shortage of skilled professionals and poor reimbursement policies hamper the Europe flowable hemostats market.

Based on material, the Europe flowable hemostats market is bifurcated into bovine gelatin & porcine gelatin. The bovine gelatin segment held 62.8% share of Europe flowable hemostats market in 2022, amassing US$ 135.41 million. It is projected to garner US$ 208.73 million by 2028 to expand at 7.5% CAGR during 2022-2028.

In terms product, the Europe flowable hemostats market is segmented into combination hemostats, passive hemostats, and active hemostats. The combination hemostats segment held 59.0% share of Europe flowable hemostats market in 2022, amassing US$ 127.14 million. It is projected to garner US$ 197.57 million by 2028 to expand at 7.6% CAGR during 2022-2028.

Based on application, the Europe flowable hemostats market is categorized into general surgery, cardiac surgery, vascular surgery, orthopedic surgery, neuro and spine surgery, and others. The general surgery segment held 33.9% share of Europe flowable hemostats market in 2022, amassing US$ 73.17 million. It is projected to garner US$ 118.05 million by 2028 to expand at 8.3% CAGR during 2022-2028.

Based on end user, the Europe flowable hemostats market is segmented into hospitals and clinics, ambulatory surgery centers, and others. The hospitals and clinics segment held 61.7% share of Europe flowable hemostats market in 2022, amassing US$ 132.99 million. It is projected to garner US$ 200.74 million by 2028 to expand at 7.1% CAGR during 2022-2028.

By country, the Europe flowable hemostats market has been categorized into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Our regional analysis states that Germany captured 24.5% share of Europe flowable hemostats market in 2022. It was assessed at US$ 52.90 million in 2022 and is likely to hit US$ 83.60 million by 2028, exhibiting a CAGR of 7.9% during 2022-2028.

Key players operating in the Europe flowable hemostats market Baxter International Inc, Ethicon (Johnson & Johnson), Pfizer Inc, Teleflex Incorporated, 3-D Matrix Medical Technology, Biom’up, and Aegis Lifesciences, among others.

In Dec-19, Johnson & Johnson’s Ethicon unit has launched its blood-stopping protein spray, designed to quickly seal off and control excessive bleeding during open surgeries or minimally invasive procedures. According to Ethicon, it’s the first fibrin sealant designed to be used without a gas propellant. Delivered in a pre-filled syringe, the spray is designed to rapidly adhere and form a clot over the bleed and has shown clinical success in high-risk patients-such as those with multiple factors including bleeding disorders, diabetes or organ failure, or patients taking blood thinners or antiplatelet therapies.

o Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe flowable hemostats market.
o Highlights key business priorities to assist companies to realign their business strategies.
o The key findings and recommendations highlight crucial progressive industry trends in Europe flowable hemostats market, thereby allowing players across the value chain to develop effective long-term strategies.
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
o Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the market, as well as those hindering it.
o Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution

TABLE OF CONTENTS

1. Introduction
1.1 Scope of the Study
1.2 the Research Team Research Report Guidance
1.3 Market Segmentation
1.3.1 Europe Flowable Hemostats Market – By Material
1.3.2 Europe Flowable Hemostats Market – By Product
1.3.3 Europe Flowable Hemostats Market – By Application
1.3.4 Europe Flowable Hemostats Market – By End User
1.3.5 Europe Flowable Hemostats Market – By Country
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Flowable Hemostats Market – Market Landscape
4.1 Overview
4.2 Europe PEST Analysis
4.3 Europe Experts Opinion
5. Europe Flowable Hemostats Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Number of Injuries and Surgical Procedures
5.1.2 Rising Geriatric Population
5.2 Market Restraints
5.2.1 Shortage of Skilled Professionals and Poor Reimbursement Policies
5.3 Market Opportunities
5.3.1 Increasing Number of Hospitals and Surgical Centers
5.4 Future Trends
5.4.1 Research and Development (R&D) Activities Leading to Product Innovations
5.5 Impact Analysis
6. Flowable Hemostats Market – Europe Analysis
6.1 Europe Flowable Hemostats Market Revenue Forecast & Analysis
6.1.1 Europe Flowable Hemostats Market Revenue Forecast & Analysis
7. Europe Flowable Hemostats Market Analysis – By Material
7.1 Europe Flowable Hemostats Market Share, by Material, 2021 and 2028 (%
7.2 Bovine Gelatin
7.2.1 Overview
7.2.2 Bovine Gelatin: Europe Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
7.3 Porcine Gelatin
7.3.1 Overview
7.3.2 Porcine Gelatin: Europe Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
8. Europe Flowable Hemostats Market- By Product
8.1 Overview
8.2 Combination Hemostat
8.2.1 Overview
8.2.2 Combination Hemostat: Europe Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
8.3 Passive Hemostat
8.3.1 Overview
8.3.2 Passive Hemostat: Europe Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
8.4 Active Hemostat
8.4.1 Overview
8.4.2 Active Hemostat: Europe Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
9. Europe Flowable Hemostats Market- By Application
9.1 Overview
9.2 General Surgery
9.2.1 Overview
9.2.2 General Surgery: Europe Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
9.3 Cardiac Surgery
9.3.1 Overview
9.3.2 Cardiac Surgery: Europe Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
9.4 Vascular Surgery
9.4.1 Overview
9.4.2 Vascular Surgery: Europe Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
9.5 Orthopedic Surgery
9.5.1 Overview
9.5.2 Orthopedic Surgery: Europe Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
9.6 Neuro and Spine Surgery
9.6.1 Overview
9.6.2 Neuro and Spine Surgery: Europe Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
9.7 Others
9.7.1 Overview
9.7.2 Others: Europe Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
10. Europe Flowable Hemostats Market Analysis – By End User
10.1 Overview
10.2 Hospitals and Clinics
10.2.1 Overview
10.2.2 Hospitals and Clinics: Europe Flowable Hemostats Market – Revenue and Forecast to 2028 (US$ Million)
10.3 Ambulatory Surgery Centers
10.3.1 Overview
10.3.2 Ambulatory Surgery Centers: Europe Flowable Hemostats Market – Revenue and Forecast to 2028 (US$ Million)
10.4 Others
10.4.1 Overview
10.4.2 Others: Europe Flowable Hemostats Market – Revenue and Forecast to 2028 (US$ Million)
11. Europe Flowable Hemostats Market Revenue and Forecasts to 2028 – Country Analysis
11.1 Europe Flowable Hemostats Market Revenue and Forecast to 2028
11.1.1 Overview
11.1.1.1 Germany: Flowable Hemostats Market – Revenue and Forecast to 2028 (USD Million)
11.1.1.1.1 Germany: Flowable Hemostats Market – Revenue and Forecast to 2028 (USD Million)
11.1.1.1.2 Germany: Flowable Hemostats Market, by Material – Revenue and Forecast to 2028 (USD Million)
11.1.1.1.3 Germany: Flowable Hemostats Market, by Product- Revenue and Forecast to 2028 (USD Million)
11.1.1.1.4 Germany: Flowable Hemostats Market, by Application- Revenue and Forecast to 2028 (USD Million)
11.1.1.1.5 Germany: Flowable Hemostats Market, End User – Revenue and Forecast to 2028 (USD Million)
11.1.1.2 UK: Flowable Hemostats Market – Revenue and Forecast to 2028 (USD Million)
11.1.1.2.1 UK: Flowable Hemostats Market – Revenue and Forecast to 2028 (USD Million)
11.1.1.2.2 UK: Flowable Hemostats Market, by Material – Revenue and Forecast to 2028 (USD Million)
11.1.1.2.3 UK: Flowable Hemostats Market, by Product- Revenue and Forecast to 2028 (USD Million)
11.1.1.2.4 UK: Flowable Hemostats Market, by Application- Revenue and Forecast to 2028 (USD Million)
11.1.1.2.5 UK: Flowable Hemostats Market, End User – Revenue and Forecast to 2028 (USD Million)
11.1.1.3 France: Flowable Hemostats Market – Revenue and Forecast to 2028 (USD Million)
11.1.1.3.1 France: Flowable Hemostats Market – Revenue and Forecast to 2028 (USD Million)
11.1.1.3.2 France: Flowable Hemostats Market, by Material – Revenue and Forecast to 2028 (USD Million)
11.1.1.3.3 France: Flowable Hemostats Market, by Product- Revenue and Forecast to 2028 (USD Million)
11.1.1.3.4 France: Flowable Hemostats Market, by Application- Revenue and Forecast to 2028 (USD Million)
11.1.1.3.5 France: Flowable Hemostats Market, End User – Revenue and Forecast to 2028 (USD Million)
11.1.1.4 Italy: Flowable Hemostats Market – Revenue and Forecast to 2028 (USD Million)
11.1.1.4.1 Italy: Flowable Hemostats Market – Revenue and Forecast to 2028 (USD Million)
11.1.1.4.2 Italy: Flowable Hemostats Market, by Material – Revenue and Forecast to 2028 (USD Million)
11.1.1.4.3 Italy: Flowable Hemostats Market, by Product- Revenue and Forecast to 2028 (USD Million)
11.1.1.4.4 Italy: Flowable Hemostats Market, by Application- Revenue and Forecast to 2028 (USD Million)
11.1.1.4.5 Italy: Flowable Hemostats Market, End User – Revenue and Forecast to 2028 (USD Million)
11.1.1.5 Spain: Flowable Hemostats Market – Revenue and Forecast to 2028 (USD Million)
11.1.1.5.1 Spain: Flowable Hemostats Market – Revenue and Forecast to 2028 (USD Million)
11.1.1.5.2 Spain: Flowable Hemostats Market, by Material – Revenue and Forecast to 2028 (USD Million)
11.1.1.5.3 Spain: Flowable Hemostats Market, by Product- Revenue and Forecast to 2028 (USD Million)
11.1.1.5.4 Spain: Flowable Hemostats Market, by Application- Revenue and Forecast to 2028 (USD Million)
11.1.1.5.5 Spain: Flowable Hemostats Market, End User – Revenue and Forecast to 2028 (USD Million)
11.1.1.6 Rest of Europe: Flowable Hemostats Market – Revenue and Forecast to 2028 (USD Million)
11.1.1.6.1 Rest of Europe: Flowable Hemostats Market – Revenue and Forecast to 2028 (USD Million)
11.1.1.6.2 Rest of Europe: Flowable Hemostats Market, by Material – Revenue and Forecast to 2028 (USD Million)
11.1.1.6.3 Rest of Europe: Flowable Hemostats Market, by Product- Revenue and Forecast to 2028 (USD Million)
11.1.1.6.4 Rest of Europe: Flowable Hemostats Market, by Application- Revenue and Forecast to 2028 (USD Million)
11.1.1.6.5 Rest of Europe: Flowable Hemostats Market, End User – Revenue and Forecast to 2028 (USD Million)
12. Europe Flowable Hemostats Market-Industry Landscape
12.1 Overview
12.2 Organic Developments
12.2.1 Overview
12.3 Inorganic Developments
12.3.1 Overview
13. Company Profiles
13.1 Baxter International Inc
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Ethicon (Johnson & Johnson)
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Pfizer Inc.
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Teleflex Incorporated
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 3-D Matrix Medical Technology
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Biom’up
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Aegis Lifesciences
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
14. Appendix
14.1 About the Research Team
14.2 Europe Glossary of Terms

LIST OF TABLES

Table 1. Germany: Flowable Hemostats Market, by Material – Revenue and Forecast to 2028 (USD Million)
Table 2. Germany: Flowable Hemostats Market, by Product- Revenue and Forecast to 2028 (USD Million)
Table 3. Germany: Flowable Hemostats Market, by Application- Revenue and Forecast to 2028 (USD Million)
Table 4. Germany: Flowable Hemostats Market, End User – Revenue and Forecast to 2028 (USD Million)
Table 5. UK: Flowable Hemostats Market, by Material – Revenue and Forecast to 2028 (USD Million)
Table 6. UK: Flowable Hemostats Market, by Product- Revenue and Forecast to 2028 (USD Million)
Table 7. UK: Flowable Hemostats Market, by Application- Revenue and Forecast to 2028 (USD Million)
Table 8. UK: Flowable Hemostats Market, End User – Revenue and Forecast to 2028 (USD Million)
Table 9. France: Flowable Hemostats Market, by Material – Revenue and Forecast to 2028 (USD Million)
Table 10. France: Flowable Hemostats Market, by Product- Revenue and Forecast to 2028 (USD Million)
Table 11. France: Flowable Hemostats Market, by Application- Revenue and Forecast to 2028 (USD Million)
Table 12. France: Flowable Hemostats Market, End User – Revenue and Forecast to 2028 (USD Million)
Table 13. Italy: Flowable Hemostats Market, by Material – Revenue and Forecast to 2028 (USD Million)
Table 14. Italy: Flowable Hemostats Market, by Product- Revenue and Forecast to 2028 (USD Million)
Table 15. Italy: Flowable Hemostats Market, by Application- Revenue and Forecast to 2028 (USD Million)
Table 16. Italy: Flowable Hemostats Market, End User – Revenue and Forecast to 2028 (USD Million)
Table 17. Spain: Flowable Hemostats Market, by Material – Revenue and Forecast to 2028 (USD Million)
Table 18. Spain: Flowable Hemostats Market, by Product- Revenue and Forecast to 2028 (USD Million)
Table 19. Spain: Flowable Hemostats Market, by Application- Revenue and Forecast to 2028 (USD Million)
Table 20. Spain: Flowable Hemostats Market, End User – Revenue and Forecast to 2028 (USD Million)
Table 21. Rest of Europe: Flowable Hemostats Market, by Material – Revenue and Forecast to 2028 (USD Million)
Table 22. Rest of Europe: Flowable Hemostats Market, by Product- Revenue and Forecast to 2028 (USD Million)
Table 23. Rest of Europe: Flowable Hemostats Market, by Application- Revenue and Forecast to 2028 (USD Million)
Table 24. Rest of Europe: Flowable Hemostats Market, End User – Revenue and Forecast to 2028 (USD Million)
Table 25. Organic Developments in the Flowable Hemostats Market
Table 26. Inorganic Developments in the Flowable Hemostats Market
Table 27. Europe Glossary of Terms

LIST OF FIGURES

Figure 1. Europe Flowable Hemostats Market Segmentation
Figure 2. Europe Flowable Hemostats Market, By Country
Figure 3. Europe Flowable Hemostats Market Overview
Figure 4. Bovine Gelatin Holds Maximum Share in Europe Flowable Hemostats Market
Figure 5. Europe Flowable Hemostats Market, by Country (US$ Million)
Figure 6. Europe Flowable Hemostats Market, Market Attractiveness
Figure 7. Europe: PEST Analysis
Figure 8. Europe Experts Opinion
Figure 9. Impact Analysis
Figure 10. Europe Flowable Hemostats Market – Revenue Forecast and Analysis – 2020- 2028
Figure 11. Europe Flowable Hemostats market Share, by Material, 2021 and 2028 (%)
Figure 12. Bovine Gelatin: Europe Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
Figure 13. Europe Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
Figure 14. Europe Flowable Hemostats Market Share, by Product, 2021 and 2028 (%)
Figure 15. Combination Hemostat: Europe Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
Figure 16. Passive Hemostat: Europe Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
Figure 17. Active Hemostat: Europe Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
Figure 18. Europe Flowable Hemostats Market Share, by Application, 2021 and 2028 (%)
Figure 19. General Surgery: Europe Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
Figure 20. Cardiac Surgery: Europe Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
Figure 21. Vascular Surgery: Europe Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
Figure 22. Orthopedic Surgery: Europe Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
Figure 23. Neuro and Spine Surgery: Europe Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
Figure 24. Others: Europe Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
Figure 25. Europe Flowable Hemostats Gown Market Share, by End User, 2021 and 2028 (%)
Figure 26. Hospitals and Clinics: Europe Flowable Hemostats Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. Ambulatory Surgery Centers: Europe Flowable Hemostats Market – Revenue and Forecast to 2028 (US$ Million)
Figure 28. Others: Europe Flowable Hemostats Market – Revenue and Forecast to 2028 (US$ Million)
Figure 29. Europe: Flowable Hemostats Market, by Key Country – Revenue (2021) (USD Million)
Figure 30. Europe: Flowable Hemostats Market, by Country, 2021 & 2028 (%)
Figure 31. Germany: Flowable Hemostats Market – Revenue and Forecast to 2028 (USD Million)
Figure 32. France: Flowable Hemostats Market – Revenue and Forecast to 2028 (USD Million)
Figure 33. Italy: Flowable Hemostats Market – Revenue and Forecast to 2028 (USD Million)
Figure 34. Spain: Flowable Hemostats Market – Revenue and Forecast to 2028 (USD Million)
Figure 35. Rest of Europe: Flowable Hemostats Market – Revenue and Forecast to 2028 (USD Million)
Figure 36. Growth Strategies in the Flowable Hemostats Market (%)

The List of Companies – Europe Flowable Hemostats Market

1. Baxter International Inc
2. Ethicon (Johnson & Johnson
3. Pfizer Inc
4. Teleflex Incorporated
5. 3-D Matrix Medical Technology
6. Biom’up
7. Aegis Lifesciences

Reviews

There are no reviews yet.

Be the first to review “Europe Flowable Hemostats Market Forecast to 2028”